ATE199745T1 - Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment - Google Patents

Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment

Info

Publication number
ATE199745T1
ATE199745T1 AT94901002T AT94901002T ATE199745T1 AT E199745 T1 ATE199745 T1 AT E199745T1 AT 94901002 T AT94901002 T AT 94901002T AT 94901002 T AT94901002 T AT 94901002T AT E199745 T1 ATE199745 T1 AT E199745T1
Authority
AT
Austria
Prior art keywords
gene fragment
antibody
fhv
recombinant antibody
fragment coding
Prior art date
Application number
AT94901002T
Other languages
English (en)
Inventor
Kazuhiko Kimachi
Hiroaki Maeda
Kiyoto Nishiyama
Sachio Tokiyoshi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE199745T1 publication Critical patent/ATE199745T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/801—Drug, bio-affecting and body treating compositions involving antibody or fragment thereof produced by recombinant dna technology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94901002T 1992-11-28 1993-11-25 Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment ATE199745T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34125592A JP3919830B2 (ja) 1992-11-28 1992-11-28 抗ネコヘルペスウイルス−１組換え抗体および該抗体をコードする遺伝子断片
PCT/JP1993/001724 WO1994012661A1 (fr) 1992-11-28 1993-11-25 Anticorps de recombinaison dirige contre l'herpes-virus felin de type 1, et fragment genique codant pour un tel anticorps

Publications (1)

Publication Number Publication Date
ATE199745T1 true ATE199745T1 (de) 2001-03-15

Family

ID=18344623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901002T ATE199745T1 (de) 1992-11-28 1993-11-25 Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment

Country Status (9)

Country Link
US (1) US5760185A (de)
EP (1) EP0671472B1 (de)
JP (1) JP3919830B2 (de)
AT (1) ATE199745T1 (de)
AU (1) AU674043B2 (de)
CA (1) CA2150346C (de)
DE (1) DE69330031T2 (de)
ES (1) ES2160115T3 (de)
WO (1) WO1994012661A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4347694B2 (ja) * 2001-10-16 2009-10-21 レイベン バイオテクノロジーズ，インコーポレイティド 癌関連抗原ｃｄ４６に結合する抗体およびその使用方法
WO2003040187A1 (en) 2001-11-08 2003-05-15 Yang Sheng Tang Company Limited Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
CA2505633A1 (en) * 2002-11-13 2004-05-27 Raven Biotechnologies, Inc. Antigen pipa and antibodies that bind thereto
JP5372500B2 (ja) 2005-06-17 2013-12-18 トレラクス リクイデーティング トラスト Ｉｌｔ３結合分子およびその使用
EP2041180B8 (de) * 2006-06-19 2014-03-05 Liquidating Trust Ilt3-bindende moleküle und verwendungen davon
AR063086A1 (es) 2006-10-02 2008-12-23 Medarex Inc Anticuerpos humanos que se unen a cxcr4 y usos de los mismos
ES2678060T3 (es) 2006-12-01 2018-08-08 E. R. Squibb & Sons, L.L.C. Anticuerpos, en particular, anticuerpos humanos, que se unen a CD22 y usos de los mismos
CL2007003622A1 (es) 2006-12-13 2009-08-07 Medarex Inc Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
NZ578354A (en) 2006-12-14 2012-01-12 Medarex Inc Antibody-partner molecule conjugates that bind cd70 and uses thereof
CA2716766A1 (en) 2008-02-27 2009-09-03 Fuso Pharmaceutical Industries, Ltd. Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
CN102325881B (zh) 2008-12-22 2014-08-20 国立大学法人北海道大学 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用
BR112012022338A2 (pt) * 2010-03-04 2017-02-14 Vet Therapeutics Inc anticorpos monoclonais direcionados a cd20
US9616120B2 (en) 2010-03-04 2017-04-11 Vet Therapeutics, Inc. Monoclonal antibodies directed to CD20
JP2013520999A (ja) * 2010-03-04 2013-06-10 ベット・セラピューティクス・インコーポレイテッド Ｃｄ５２に対するモノクローナル抗体
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
UY34887A (es) 2012-07-02 2013-12-31 Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
WO2014168933A1 (en) * 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
WO2018156180A1 (en) 2017-02-24 2018-08-30 Kindred Biosciences, Inc. Anti-il31 antibodies for veterinary use
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
JP7264353B2 (ja) 2018-05-24 2023-04-25 国立大学法人北海道大学 新規ベクターおよびその利用
JP7524065B2 (ja) 2018-07-25 2024-07-29 イノベント バイオロジックス （スウツォウ） カンパニー，リミテッド 抗ｔｉｇｉｔ抗体及びその使用
CN109762067B (zh) 2019-01-17 2020-02-28 北京天广实生物技术股份有限公司 结合人Claudin 18.2的抗体及其用途
US10570210B1 (en) 2019-03-04 2020-02-25 Beijing Mabworks Biotech Co.Ltd Antibodies binding CD40 and uses thereof
CN115087673B (zh) 2020-02-27 2025-02-18 正大天晴药业集团股份有限公司 结合il4r的抗体及其用途
CA3178564A1 (en) 2020-05-12 2021-11-18 Zhengping Zhang St2 antigen binding protein
WO2023093816A1 (zh) 2021-11-25 2023-06-01 诺纳生物（苏州）有限公司 抗Siglec-15抗体及其应用
EP4495138A1 (de) 2022-03-18 2025-01-22 Beijing Mabworks Biotech Co., Ltd B7-h3-bindender antikörper und verwendung davon
CN115850453B (zh) * 2022-12-16 2024-09-10 北京纳百生物科技有限公司 针对猫疱疹病毒1型gD蛋白的特异性抗体及用途
CN116284350B (zh) * 2023-05-06 2023-08-04 泰州博莱得利生物科技有限公司 一种猫疱疹病毒单克隆抗体及其制备方法和应用
CN117607431B (zh) * 2023-06-30 2024-10-25 深圳赫兹生命科学技术有限公司 猫疱疹病毒的elisa检测试剂
CN118599004B (zh) * 2024-06-11 2024-11-26 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 一种抗猫IgG单克隆抗体或其抗原结合片段及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH01309785A (ja) 1988-06-06 1989-12-14 Babcock Hitachi Kk ミドルパルスｔｉｇ溶接装置
JP2811095B2 (ja) * 1989-09-30 1998-10-15 財団法人化学及血清療法研究所 ネコ免疫グロブリンκ鎖の定常領域をコードする遺伝子断片およびマウス×ネコキメラ抗体
CA2022959C (en) * 1989-08-10 2001-03-20 Hiroaki Maeda Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin
JP2811102B2 (ja) 1989-12-28 1998-10-15 財団法人化学及血清療法研究所 ネコ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×ネコキメラ抗体
JP2811086B2 (ja) * 1989-08-10 1998-10-15 財団法人化学及血清療法研究所 ネコ×マウスヘテロハイブリドーマおよびネコ免疫グロブリンλ鎖の定常領域をコードする遺伝子断片
JPH03123486A (ja) * 1989-10-06 1991-05-27 Hitachi Ltd 膜蛋白質の遺伝子工学的生産方法

Also Published As

Publication number Publication date
DE69330031T2 (de) 2001-07-19
EP0671472B1 (de) 2001-03-14
US5760185A (en) 1998-06-02
EP0671472A4 (de) 1997-11-19
JPH06217786A (ja) 1994-08-09
ES2160115T3 (es) 2001-11-01
AU5596194A (en) 1994-06-22
CA2150346A1 (en) 1994-06-09
DE69330031D1 (de) 2001-04-19
AU674043B2 (en) 1996-12-05
JP3919830B2 (ja) 2007-05-30
WO1994012661A1 (fr) 1994-06-09
CA2150346C (en) 2005-08-09
EP0671472A1 (de) 1995-09-13

Similar Documents

Publication Publication Date Title
ATE199745T1 (de) Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment
ATE340590T1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
EP0960936A4 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
CA2114015A1 (en) Recombinant antibodies for human therapy
EP1244708B8 (de) Verfahren zur behandlung von entzündungen
EP0675904A4 (de) Humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch.
PT733069E (pt) Antigenios ctla-8 de primata purificados e reagentes relacionados
IL138801A0 (en) Humanized antibody against human tissue factor and process for the preparation thereof
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
EP1329459A3 (de) Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon
DK1015477T3 (da) 32 humane sekreterede proteiner
AU6714290A (en) Method of treating infectious bursal disease virus
EP0678523A4 (de) Rekombinanter anti-hiv antikörper und seine herstellung.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
EP0184575A3 (en) Transformed yeasts producing lysozyme, plasmids used for this transformation, and uses thereof
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
ATE139704T1 (de) Verwendung und verabreichung von enzymen
DE69328799D1 (de) Anti-Felincalicivirus rekombinanter Antikörper und dafür kodierendes Gen
DE59611293D1 (de) Protein mit dnase-aktivität
EP0648841A3 (de) Genomische DNS für menschliche Cholesterol-7-alpha Hydroxylase und Verfahren dessen Verwendung.
ATE230799T1 (de) Verkürzte, menschliche cholesterol-7-alpha- hydroxylase, verfahren zur dessen herstellung und deren verwendung
GB2229725B (en) A method of enhancing neutralising antibody activity in human or animal sera or in other body secreations
Blaha Epizootiological characteristics of transmissible diseases- importance to immunoprophylaxis(review paper).

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties